Drug-tunable multidimensional synthetic gene control using inducible degron-tagged dCas9 effectors

Abstract

Deactivated Cas9 fused to transactivation domains can be used to control gene expression, however its presence can prevent rapid switching between different regulatory states. Here the authors generate conditionally degradable dCas9 and Cpf1 proteins for multidimensional control of functional activity.